The Coca-Cola Co (NYSE: KO) is back to tinkering with its formulas. This time it is with a newly announced update to its Coca-Cola Zero Sugar product, the successor to the Coca-Cola Zero that was discontinued in 2017 after 12 years on the market.
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week stoked rate hike fears, and exerted negative pressure on stocks.
There were very few stock-specific catalysts, barring a few preannouncements, stock offerings, and a slew of initial public offerings.
The rise in popularity of Bitcoin (CRYPTO: BTC) and other cryptocurrencies has put pressure on the U.S. Federal Reserve and other central banks around the world to create their own central bank digital currencies, or CBDCs.
Benzinga has examined the prospects for many investor favorite stocks over the past week.
Last week's bullish calls included the iPhone maker, the EV leader and a big bank.
A top automaker, a casino stock and a REIT were among the bearish calls seen.
The SPDR S&P 500 ETF (NYSE: SPY) continued to pull back from its $437.92 all-time high on Friday. The SPY reached the record price twice on Tuesday and Wednesday this week, creating a bearish double top pattern.
The overcast skies looming over Louis Armstrong New Orleans International Airport did nothing to quash the spirit of city officials — including Mayor LaToya Cantrell — and airport functionaries watching, clapping or dancing along with the Treme Brass Band, two Zulu Tramps and an oversized Louis Armstrong bobble head-like figure as they all gathered by a gate Thursday.
CNBC's "Rapid Fire" panel reacted to the recent comments from Tesla Inc (NASDAQ: TSLA) CEO Elon Musk regarding Tesla's Cybertruck Friday on CNBC's "The Exchange."